{
    "clinical_study": {
        "@rank": "104473", 
        "arm_group": {
            "arm_group_label": "PLD", 
            "arm_group_type": "Experimental", 
            "description": "dose finding study of PLD in combination with Carboplatin"
        }, 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells.\n\n      PURPOSE: Phase I/II trial to study the effectiveness of combining liposomal doxorubicin with\n      carboplatin in treating patients who have gynecologic cancer."
        }, 
        "brief_title": "Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer", 
        "condition": [
            "Cervical Cancer", 
            "Endometrial Cancer", 
            "Fallopian Tube Cancer", 
            "Ovarian Cancer", 
            "Sarcoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Uterine Cervical Neoplasms", 
                "Ovarian Neoplasms", 
                "Fallopian Tube Neoplasms", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the maximum tolerated dose of doxorubicin HCl liposome when administered with\n           carboplatin in patients with gynecological tumors.\n\n        -  Determine the dose-limiting toxicity of this regimen in these patients.\n\n        -  Determine the kind, frequency, severity, and duration of adverse events in patients\n           treated with this regimen.\n\n      OUTLINE: This is a multicenter, dose-escalation study of doxorubicin HCl liposome.\n\n      Patients receive doxorubicin HCl liposome IV over 60 minutes followed by carboplatin IV over\n      30 minutes on day 1. Treatment repeats every 28 days for 6 courses.\n\n      Cohorts of 3-6 patients receive escalating doses of doxorubicin HCl liposome until the\n      maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at\n      which at least 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. Once the MTD is\n      determined, additional patients are accrued and treated at the MTD as above.\n\n      Patients are followed at 4-6 weeks and then every 3 months thereafter.\n\n      PROJECTED ACCRUAL: A total of 12-24 patients will be accrued for this study within 1 year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed fallopian tube cancer, Muellerian mixed\n             tumor, endometrial cancer, uterine sarcoma, ovarian cancer with sarcoma parts, or\n             cervical cancer\n\n               -  No ovarian epithelial cancer\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Performance status:\n\n          -  ECOG 0-2 OR\n\n          -  Karnofsky 70-100%\n\n        Life expectancy:\n\n          -  At least 3 months\n\n        Hematopoietic:\n\n          -  Absolute neutrophil count at least 1,500/mm3\n\n          -  Platelet count at least 100,000/mm3\n\n          -  Hemoglobin greater than 10.0 g/dL\n\n        Hepatic:\n\n          -  Bilirubin no greater than 1.25 times upper limit of normal\n\n        Renal:\n\n          -  Glomerular filtration rate at least 60 mL/min\n\n        Cardiovascular:\n\n          -  No atrial or ventricular arrhythmias\n\n          -  No congestive heart failure even if stabilized on medication\n\n          -  No New York Heart Association class III or IV heart disease\n\n          -  No myocardial infarction within the past 6 months\n\n        Other:\n\n          -  No pre-existing sensory or motor neuropathy grade 2 or greater\n\n          -  No active infection\n\n          -  No other serious medical condition that would preclude study\n\n          -  Not pregnant\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  At least 4 weeks since prior immunotherapy\n\n        Chemotherapy:\n\n          -  No more than 1 prior chemotherapy regimen for the malignancy\n\n          -  No other concurrent chemotherapy\n\n        Endocrine therapy:\n\n          -  Prior hormonal therapy within the past 10 days allowed\n\n          -  No concurrent hormonal therapy\n\n        Radiotherapy:\n\n          -  At least 6 weeks since prior radiotherapy to no more than 25% of bone marrow\n\n        Surgery:\n\n          -  Not specified\n\n        Other:\n\n          -  At least 30 days since prior experimental agents\n\n          -  No other concurrent therapies that would preclude study\n\n          -  No concurrent participation in another study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "63", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 8, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00032162", 
            "org_study_id": "CDR0000069262", 
            "secondary_id": [
                "AGOSG-AGO-GYN-2", 
                "EU-20147"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "PLD", 
                "description": "AUC 6 q4w", 
                "intervention_name": "carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "PLD", 
                "description": "20/30/40 mg/qm q4w  Dose finding study", 
                "intervention_name": "pegylated liposomal doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxorubicin", 
                "Carboplatin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "stage III cervical cancer", 
            "recurrent cervical cancer", 
            "stage IB cervical cancer", 
            "stage IIB cervical cancer", 
            "stage IVB cervical cancer", 
            "stage IA cervical cancer", 
            "stage IIA cervical cancer", 
            "stage IVA cervical cancer", 
            "stage I endometrial carcinoma", 
            "stage II endometrial carcinoma", 
            "stage III endometrial carcinoma", 
            "stage IV endometrial carcinoma", 
            "recurrent endometrial carcinoma", 
            "fallopian tube cancer", 
            "stage I uterine sarcoma", 
            "stage II uterine sarcoma", 
            "stage III uterine sarcoma", 
            "stage IV uterine sarcoma", 
            "recurrent uterine sarcoma", 
            "ovarian sarcoma", 
            "ovarian carcinosarcoma"
        ], 
        "lastchanged_date": "May 29, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/AGOSG-AGO-GYN-2"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "D-10117"
                    }, 
                    "name": "Universitaetsklinikum Charite"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany", 
                        "zip": "D-28205"
                    }, 
                    "name": "Zentralkrankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "D-01307"
                    }, 
                    "name": "Medizinische Klinik I"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duesseldorf", 
                        "country": "Germany", 
                        "zip": "D-40225"
                    }, 
                    "name": "Universitaetsklinik Duesseldorf"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dusseldorf", 
                        "country": "Germany", 
                        "zip": "DOH-40217"
                    }, 
                    "name": "Evangelisches Krankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "zip": "60596"
                    }, 
                    "name": "Klinikum der J.W. Goethe Universitaet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt Am Main", 
                        "country": "Germany", 
                        "zip": "65929"
                    }, 
                    "name": "Staedtisches Krankenhaus FFM-Hoechst"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gottingen", 
                        "country": "Germany", 
                        "zip": "D-37075"
                    }, 
                    "name": "Universitaetsklinik Goettingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greifswald", 
                        "country": "Germany", 
                        "zip": "D-17487"
                    }, 
                    "name": "Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30659"
                    }, 
                    "name": "Frauenklinik der MHH"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlsruhe", 
                        "country": "Germany", 
                        "zip": "D-76137"
                    }, 
                    "name": "Vincentius Krankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "D-24105"
                    }, 
                    "name": "Christian-Albrechts University of Kiel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany", 
                        "zip": "39108"
                    }, 
                    "name": "Klinik der Otto - v. - Guericke - Universitat"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muenster", 
                        "country": "Germany", 
                        "zip": "D-48129"
                    }, 
                    "name": "Klinik und Poliklinik fuer Kinderheilkunde"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich (Muenchen)", 
                        "country": "Germany", 
                        "zip": "D-81377"
                    }, 
                    "name": "Klinikum Grosshadern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich (Muenchen)", 
                        "country": "Germany", 
                        "zip": "D-81675"
                    }, 
                    "name": "Klinikum Rechts Der Isar/Technische Universitaet Muenchen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tuebingen", 
                        "country": "Germany", 
                        "zip": "D-72076"
                    }, 
                    "name": "Universitaetsklinikum Tuebingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "D-89075"
                    }, 
                    "name": "Universitaet Ulm"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "zip": "D-65199"
                    }, 
                    "name": "Dr. Hors t- Schmidt - Kliniken"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors", 
        "overall_official": {
            "affiliation": "Dr. Horst-Schmidt-Kliniken", 
            "last_name": "Andreas du Bois, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "DL DLT", 
            "safety_issue": "Yes", 
            "time_frame": "DLT during first 3 cycles"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00032162"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "17910981", 
            "citation": "du Bois A, Pfisterer J, Burchardi N, Loibl S, Huober J, Wimberger P, Burges A, Stahle A, Jackisch C, Kolbl H. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut). Gynecol Oncol. 2007 Oct 1; [Epub ahead of print]"
        }, 
        "source": "AGO Study Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGO Study Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2012"
    }, 
    "geocoordinates": {
        "Christian-Albrechts University of Kiel": "54.323 10.123", 
        "Dr. Hors t- Schmidt - Kliniken": "50.063 8.243", 
        "Evangelisches Krankenhaus": "51.221 6.81", 
        "Frauenklinik der MHH": "52.384 9.727", 
        "Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet": "54.087 13.392", 
        "Klinik der Otto - v. - Guericke - Universitat": "52.131 11.629", 
        "Klinik und Poliklinik fuer Kinderheilkunde": "51.951 7.626", 
        "Klinikum Grosshadern": "48.145 11.558", 
        "Klinikum Rechts Der Isar/Technische Universitaet Muenchen": "48.145 11.558", 
        "Klinikum der J.W. Goethe Universitaet": "50.111 8.682", 
        "Medizinische Klinik I": "51.031 13.757", 
        "Staedtisches Krankenhaus FFM-Hoechst": "50.111 8.682", 
        "Universitaet Ulm": "48.404 9.979", 
        "Universitaetsklinik Duesseldorf": "51.221 6.81", 
        "Universitaetsklinik Goettingen": "51.538 9.93", 
        "Universitaetsklinikum Charite": "52.524 13.406", 
        "Universitaetsklinikum Tuebingen": "48.521 9.059", 
        "Vincentius Krankenhaus": "49.009 8.38", 
        "Zentralkrankenhaus": "53.085 8.821"
    }
}